Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
04/2009
04/14/2009US7517894 Endothelial growth factor; angiogenesis inhibitor; antitumor agents; skin disorders; endometriosis; Crohn's disease; leukemia; antiarthritic agents
04/14/2009US7517879 Pyrrolidine derivatives as factor Xa inhibitors
04/14/2009US7517877 5-substituted-alkylaminopyrazole derivatives as pesticides
04/14/2009US7517875 Piperidine derivatives having CCR3 antagonism
04/14/2009US7517535 Agonists and antagonists of nicotinergic acetylcholine receptors of insects like fleas, lice and flies, on humans or animals; chloronicotinyl insecticides such as imidaclopridas veterinary medicine; collars; tags
04/14/2009US7517517 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
04/14/2009CA2409841C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
04/14/2009CA2408934C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
04/14/2009CA2256007C Substituted heterocyclic benzocycloalkenes and their use as analgesic
04/09/2009WO2009046416A1 Anilinopyrimidines as jak kinase inhibitors
04/09/2009WO2009045313A2 Oxypiperidine derivatives as histamine receptor antagonists
04/09/2009WO2009044788A1 Benzoxazinone derivative
04/09/2009WO2009044250A1 New compounds as adenosine a1 receptor antagonists
04/09/2009WO2009044162A1 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use
04/09/2009WO2009043884A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors
04/09/2009WO2009043883A1 Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors
04/09/2009WO2009026227A3 Highly selective sigma receptor ligands
04/09/2009WO2009022311A3 1,2-diamido-ethylene derivatives as orexin antagonists
04/09/2009WO2008155666A3 Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
04/09/2009WO2008152093A3 Diaminopyrimidines as modulators of the ep2 receptor
04/09/2009WO2008121592A3 Acetyl coenzyme a carboxylase inhibitors
04/09/2009WO2005054429A3 Synthesis of the c1-c6 keto-acid synthon of the epothilones
04/09/2009US20090093527 [3-(2-{(3S)-3-[2-(Trifluoromethyl)phenoxy]pyrrolidin-1-yl}-1,3-thiazol-5-yl)-1,2,4-oxadiazol-5-yl]methanol, useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disorders, atherosclerosis, obesity, diabetes and fatty liver
04/09/2009US20090093507 Cdk inhibitors containing a zinc binding moiety
04/09/2009US20090093478 N-aroyl cyclic amines
04/09/2009US20090093455 Quinolone analogs and methods related thereto
04/09/2009US20090093452 Pyrrole, Thiophene, Furan, Imidazole, Oxazole, and Thiazole Derivatives
04/09/2009US20090093416 Caspase inhibitors and uses thereof
04/09/2009DE4448032B4 Zusammensetzung enthaltend organische Materialien und 3-Aryl-benzofuranone als Stabilisatoren A composition comprising organic materials and 3-aryl-benzofuranones as stabilizers
04/09/2009DE102007047735A1 Thiazolderivate Thiazole derivatives
04/09/2009CA2738980A1 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use
04/09/2009CA2701406A1 Benzoxazinone derivative
04/09/2009CA2701124A1 C-met protein kinase inhibitors
04/09/2009CA2700963A1 Oxypiperidine derivatives and methods of use thereof
04/09/2009CA2700526A1 New compounds as adenosine a1 receptor antagonists
04/08/2009EP2045242A1 Heterocyclic compounds having inhibitory activity against HIV integrase
04/08/2009EP2045238A1 Bridged cyanine compounds and optical recording materials containing the same
04/08/2009EP2045237A1 Pyrrole compounds as inhibitors of mycrobacteria, synthesis thereof and intermediates thereto
04/08/2009EP2044939A1 Therapeutic agent for liver fibrosis
04/08/2009EP2044066A2 Crystalline forms of n-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl] thio]-2-thiazolyl]-4-piperidinecarboxamide
04/08/2009EP2044062A1 Indole compounds
04/08/2009EP2044060A1 Fungicide hydroximoyl-tetrazole derivatives
04/08/2009EP2044057A2 Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use
04/08/2009EP2044052A1 Fungicide hydroximoyl-tetrazole derivatives
04/08/2009EP2044041A2 Isothiazolidines useful in the treatment of ocular hypertensive conditions
04/08/2009EP2044038A2 Novel piperazines, pharmaceutical compositions and methods of use thereof
04/08/2009EP2044031A1 2-(heteroaryl) alkyl indazole 6-phenyl and thienyl methyl amide as thrombin inhibitors
04/08/2009EP2044028A2 Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif)
04/08/2009EP2043993A2 Cyclopentane derivatives as antiglaucoma agents
04/08/2009EP2043744A2 Chemical compounds
04/08/2009EP2043441A1 Fungicide hydroximoyl-tetrazole derivatives
04/08/2009EP1718667A4 Heterocyclic self-immolative linkers and conjugates
04/08/2009EP1668162B1 Detection of immobilized nucleic acid
04/08/2009EP1442026B1 Triazole derivatives as cyclooxygenase (cox) inhibitors
04/08/2009EP1212299B1 Substituted piperidine compounds useful as modulators of chemokine receptor activity
04/08/2009CN101405283A HIV inhibiting 5-amido substituted pyrimidines
04/08/2009CN101405282A Aurora kinase modulators and method of use
04/08/2009CN101405278A Novel heterocyclic NF-kB inhibitors
04/08/2009CN101405275A Triazolone derivative
04/08/2009CN101405270A Pyrazoles as 11-beta-HSD-1
04/08/2009CN101402554A 2- and 2,5-substituted phenylketo-enols
04/08/2009CN100475810C Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists
04/08/2009CN100475796C Thiazole derivatives as cannabinoid receptor modulators
04/08/2009CN100475792C Novel gamma-secretase inhibitors
04/08/2009CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
04/07/2009US7514570 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (GnRH) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
04/07/2009US7514565 3,5-Difluoropyridines
04/07/2009US7514564 Substituted amine derivatives and methods of use
04/07/2009US7514557 Hepatitis C; preparing 8-bromo-7-alkoxyquinolines 2-substituted with a hetercyclic ring having an amine, carbamate, amine or urea group an 4-substituted with a 3-prolineoxy- group or derivative; intermediates
04/07/2009US7514461 Chroman derivatives
04/07/2009US7514460 Benzazole analogues and uses thereof
04/07/2009US7514459 Gamma-secretase inhibitors
04/07/2009US7514458 Heterocyclic-substituted benzamide derivatives, e.g., benzyl [2-(4-{1-[5-(5-tert-Butyl-3-methanesulfonylamino-2-methoxy-phenylcarbamoyl)-2-methyl-phenyl]-1H-1,2,3-triazol-4-yl}-2-phenyl-2H-pyrazol-3-yl)-ethyl]-carbamate; inhibit production of cytokines; useful for treating chronic inflammatory disease
04/07/2009US7514456 Nicotinamide derivatives useful as p38 inhibitors
04/07/2009US7514445 Heteroaryl amines as glycogen synthase kinase 3β inhibitors (GSK3 inhibitors)
04/07/2009US7514439 Oxime derivative and preparations thereof
04/07/2009US7514437 2-(2,4-difluorophenyl)-2-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-isobutyl-2,5-dioxopiperazin-1-yl]-N,N-dimethylethanamide; to suppress uterine contractions; cyclization of leucine analogs
04/07/2009US7514431 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity
04/07/2009US7514430 Nitrogen compounds such as N-phenyl-N'-{(1R,2S)-2-[(2S)-2-benzyl-6-oxo-morpholin-4-yl-methyl]-cyclohexyl }-urea, used to control chemotactic cytokines, and administered for the prevention of asthma or allergies; inhibition of the migration of eosinophils
04/07/2009US7514429 Benzoxazinone-derived compounds, their preparation and use as medicaments
04/07/2009US7514428 Pesticidal 1-aryl-3-amidoxime-pyrazole derivatives
04/07/2009US7514225 detecting drugs that inhibits the binding of macrophage migration inhibitory factor (MIF) to an antimacrophage migration inhibitor factor monoclonal or polyclonal antibody; drug screening
04/07/2009CA2415890C N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
04/07/2009CA2393757C Cycloamine ccr5 receptor antagonists
04/07/2009CA2381243C 1-cycloalkylpyrazoyl-benzoyl derivatives
04/07/2009CA2373880C Isoquinoline derivatives or salts thereof
04/07/2009CA2352505C Epothilone derivatives and their use as antitumor agents
04/07/2009CA2352503C Il-5 inhibiting 6-azauracil derivatives
04/07/2009CA2281133C Multiple-agents-binding compound and use thereof
04/07/2009CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease
04/02/2009WO2009042694A1 (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating
04/02/2009WO2009042485A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity
04/02/2009WO2009042435A1 Pyridin-2 -yl-amino-i, 2, 4 -thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
04/02/2009WO2009041559A1 Indazole acrylic acid amide compound
04/02/2009WO2009040755A2 Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof ans intermediates thereto
04/02/2009WO2009039944A1 Phenothiazine derivative having a double bond, method for the production thereof, and use thereof as a pharmaceutical
04/02/2009WO2009039553A1 Benzothiazole compounds
04/02/2009WO2009014910A3 N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 receptor for the treatment of diabetes and metabolic disorders
04/02/2009WO2009011880A3 Heterocyclic modulators of pkb
04/02/2009WO2009010299A8 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators